Aspira Pathlab & Diagnostics Shareholding

Aspira Pathlab & Diagnostics Ltd Shareholding Pattern

The Aspira Pathlab & Diagnostics Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Aspira Pathlab & Diagnostics Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Aspira Pathlab & Diagnostics Ltd (NSE: , BSE: 540788) operates in the Health services sector and Medical/Nursing services industry. Monitoring the Aspira Pathlab & Diagnostics Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Aspira Pathlab & Diagnostics Ltd Shareholding Pattern (Latest)

The latest Aspira Pathlab & Diagnostics Ltd shareholding for Dec 2025 is:

• Promoters: 18.39%
• FII: 0%
• DII: 0%
• Public: 81.61%
• Government: 0%

Promoter holding in Aspira Pathlab & Diagnostics Ltd remains stable, reflecting consistent long-term commitment.

Aspira Pathlab & Diagnostics Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Aspira Pathlab & Diagnostics Ltd.

• Dec 2025: 18.39%
• Sept 2025: 18.39%
• Jun 2025: 18.39%
• Mar 2025: 18.39%
• Dec 2024: 18.55%

Promoter stake remains largely stable, showing consistent ownership structure.

Aspira Pathlab & Diagnostics Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Aspira Pathlab & Diagnostics Ltd.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Aspira Pathlab & Diagnostics Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

DII holdings remain stable, reflecting steady institutional participation.

Aspira Pathlab & Diagnostics Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 81.61%
• Sept 2025: 81.61%
• Jun 2025: 81.61%
• Mar 2025: 81.61%
• Dec 2024: 81.45%

Public holding remains stable with consistent retail participation.

Aspira Pathlab & Diagnostics Ltd Government Holding

Government holding in Aspira Pathlab & Diagnostics Ltd currently stands at 0%.

Aspira Pathlab & Diagnostics Ltd operates without significant government ownership.

Aspira Pathlab & Diagnostics Ltd Shareholding Analysis Summary

The Aspira Pathlab & Diagnostics Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Aspira Pathlab & Diagnostics Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Aspira Pathlab & Diagnostics Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.